Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Adiponectin attenuates human eosinophil adhesion and chemotaxis: implications in allergic inflammation.

Yamamoto R, Ueki S, Moritoki Y, Kobayashi Y, Oyamada H, Konno Y, Tamaki M, Itoga M, Takeda M, Ito W, Chihara J.

J Asthma. 2013 Oct;50(8):828-35. doi: 10.3109/02770903.2013.816725. Epub 2013 Jul 17.

PMID:
23777560
2.

Staphylococcus aureus enterotoxins A and B inhibit human and mice eosinophil chemotaxis and adhesion in vitro.

Squebola-Cola DM, De Mello GC, Anhê GF, Condino-Neto A, DeSouza IA, Antunes E.

Int Immunopharmacol. 2014 Dec;23(2):664-71. doi: 10.1016/j.intimp.2014.10.020. Epub 2014 Oct 27.

PMID:
25445958
3.

The effect of pharmacological PI3Kγ inhibitor on eotaxin-induced human eosinophil functions.

Saito Y, Takeda M, Nishikawa J, Konno Y, Tamaki M, Itoga M, Kobayashi Y, Moritoki Y, Ito W, Chihara J, Ueki S.

Pulm Pharmacol Ther. 2014 Apr;27(2):164-9. doi: 10.1016/j.pupt.2013.11.006. Epub 2013 Dec 9.

PMID:
24333185
4.

Macrophage-derived chemokine induces human eosinophil chemotaxis in a CC chemokine receptor 3- and CC chemokine receptor 4-independent manner.

Bochner BS, Bickel CA, Taylor ML, MacGlashan DW Jr, Gray PW, Raport CJ, Godiska R.

J Allergy Clin Immunol. 1999 Mar;103(3 Pt 1):527-32.

PMID:
10069890
5.

2B4 (CD244) is involved in eosinophil adhesion and chemotaxis, and its surface expression is increased in allergic rhinitis after challenge.

El-Shazly AE, Henket M, Lefebvre PP, Louis R.

Int J Immunopathol Pharmacol. 2011 Oct-Dec;24(4):949-60.

PMID:
22230401
6.

Thymic stromal lymphopoietin induces chemotactic and prosurvival effects in eosinophils: implications in allergic inflammation.

Wong CK, Hu S, Cheung PF, Lam CW.

Am J Respir Cell Mol Biol. 2010 Sep;43(3):305-15. doi: 10.1165/rcmb.2009-0168OC. Epub 2009 Oct 20.

PMID:
19843704
7.

The CCR3 receptor is involved in eosinophil differentiation and is up-regulated by Th2 cytokines in CD34+ progenitor cells.

Lamkhioued B, Abdelilah SG, Hamid Q, Mansour N, Delespesse G, Renzi PM.

J Immunol. 2003 Jan 1;170(1):537-47.

8.

The synthetic PPARgamma agonist troglitazone inhibits eotaxin-enhanced eosinophil adhesion to ICAM-1-coated plates.

Hirasawa H, Chiba T, Ueki S, Kamada Y, Ito W, Takeda M, Fujita M, Kato H, Kayaba H, Chihara J.

Int Arch Allergy Immunol. 2008;146 Suppl 1:11-5. doi: 10.1159/000126054. Epub 2008 May 27.

PMID:
18504400
9.

Inhibition effects of Moutan Cortex Radicis on secretion of eotaxin in A549 human epithelial cells and eosinophil migration.

Kim J, Lee H, Lee Y, Oh BG, Cho C, Kim Y, Shin M, Hong M, Jung SK, Bae H.

J Ethnopharmacol. 2007 Nov 1;114(2):186-93. Epub 2007 Aug 15.

PMID:
17881168
10.

Eotaxin triggers eosinophil-selective chemotaxis and calcium flux via a distinct receptor and induces pulmonary eosinophilia in the presence of interleukin 5 in mice.

Rothenberg ME, Ownbey R, Mehlhop PD, Loiselle PM, van de Rijn M, Bonventre JV, Oettgen HC, Leder P, Luster AD.

Mol Med. 1996 May;2(3):334-48.

11.

The role of platelet-derived growth factor receptor in eotaxin signaling of eosinophils.

Adachi T, Hanaka S, Yano T, Yamamura K, Yoshihara H, Nagase H, Chihara J, Ohta K.

Int Arch Allergy Immunol. 2006;140 Suppl 1:28-34. Epub 2006 Jun 9.

PMID:
16772724
12.

Increased expression of eotaxin in bronchoalveolar lavage and airways of asthmatics contributes to the chemotaxis of eosinophils to the site of inflammation.

Lamkhioued B, Renzi PM, Abi-Younes S, Garcia-Zepada EA, Allakhverdi Z, Ghaffar O, Rothenberg MD, Luster AD, Hamid Q.

J Immunol. 1997 Nov 1;159(9):4593-601.

PMID:
9379061
13.

CCR3-active chemokines promote rapid detachment of eosinophils from VCAM-1 in vitro.

Tachimoto H, Burdick MM, Hudson SA, Kikuchi M, Konstantopoulos K, Bochner BS.

J Immunol. 2000 Sep 1;165(5):2748-54.

14.

Human eosinophil adhesion and degranulation stimulated with eotaxin and RANTES in vitro: lack of interaction with nitric oxide.

Lintomen L, Franchi G, Nowill A, Condino-Neto A, de Nucci G, Zanesco A, Antunes E.

BMC Pulm Med. 2008 Aug 12;8:13. doi: 10.1186/1471-2466-8-13.

15.

Obesity increases eosinophil activity in asthmatic children and adolescents.

Grotta MB, Squebola-Cola DM, Toro AA, Ribeiro MA, Mazon SB, Ribeiro JD, Antunes E.

BMC Pulm Med. 2013 Jun 18;13:39. doi: 10.1186/1471-2466-13-39.

16.

Cloning and characterization of the guinea pig eosinophil eotaxin receptor, C-C chemokine receptor-3: blockade using a monoclonal antibody in vivo.

Sabroe I, Conroy DM, Gerard NP, Li Y, Collins PD, Post TW, Jose PJ, Williams TJ, Gerard CJ, Ponath PD.

J Immunol. 1998 Dec 1;161(11):6139-47.

17.

Mast cell beta-tryptase selectively cleaves eotaxin and RANTES and abrogates their eosinophil chemotactic activities.

Pang L, Nie M, Corbett L, Sutcliffe A, Knox AJ.

J Immunol. 2006 Mar 15;176(6):3788-95.

18.

Chemokines induce eosinophil degranulation through CCR-3.

Fujisawa T, Kato Y, Nagase H, Atsuta J, Terada A, Iguchi K, Kamiya H, Morita Y, Kitaura M, Kawasaki H, Yoshie O, Hirai K.

J Allergy Clin Immunol. 2000 Sep;106(3):507-13.

PMID:
10984371
19.

Contribution of eotaxin-1 to eosinophil chemotactic activity of moderate and severe asthmatic sputum.

Dent G, Hadjicharalambous C, Yoshikawa T, Handy RL, Powell J, Anderson IK, Louis R, Davies DE, Djukanovic R.

Am J Respir Crit Care Med. 2004 May 15;169(10):1110-7. Epub 2004 Mar 4.

PMID:
15001461
20.

Hepatocyte growth factor attenuates eotaxin and PGD2-induced chemotaxis of human eosinophils.

Ito W, Chiba T, Kanehiro A, Kato H, Yamaguchi K, Ueki S, Kayaba H, Chihara J.

Allergy. 2007 Apr;62(4):415-22.

Supplemental Content

Support Center